Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Herpes simplex virus type 1 preferentially targets human colon carcinoma: role of extracellular matrix.

Kolodkin-Gal D, Zamir G, Edden Y, Pikarsky E, Pikarsky A, Haim H, Haviv YS, Panet A.

J Virol. 2008 Jan;82(2):999-1010. Epub 2007 Oct 31.

2.

Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.

Pawlik TM, Nakamura H, Mullen JT, Kasuya H, Yoon SS, Chandrasekhar S, Chiocca EA, Tanabe KK.

Cancer. 2002 Sep 1;95(5):1171-81.

3.

Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect.

Kolodkin-Gal D, Edden Y, Hartshtark Z, Ilan L, Khalaileh A, Pikarsky AJ, Pikarsky E, Rabkin SD, Panet A, Zamir G.

Gene Ther. 2009 Jul;16(7):905-15. doi: 10.1038/gt.2009.44. Epub 2009 May 14.

PMID:
19440231
4.

Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.

Coukos G, Makrigiannakis A, Montas S, Kaiser LR, Toyozumi T, Benjamin I, Albelda SM, Rubin SC, Molnar-Kimber KL.

Cancer Gene Ther. 2000 Feb;7(2):275-83.

5.

Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin.

Mullen JT, Donahue JM, Chandrasekhar S, Yoon SS, Liu W, Ellis LM, Nakamura H, Kasuya H, Pawlik TM, Tanabe KK.

Cancer. 2004 Aug 15;101(4):869-77.

7.

A novel system to study adenovirus tropism to normal and malignant colon tissues.

Kolodkin-Gal D, Zamir G, Pikarski E, Pikarski A, Shimony N, Wu H, Haviv YS, Panet A.

Virology. 2007 Jan 5;357(1):91-101. Epub 2006 Sep 7.

8.

Herpes simplex virus 1 (HSV-1) for cancer treatment.

Shen Y, Nemunaitis J.

Cancer Gene Ther. 2006 Nov;13(11):975-92. Epub 2006 Apr 7. Review.

PMID:
16604059
9.
10.

An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma.

Yoon SS, Nakamura H, Carroll NM, Bode BP, Chiocca EA, Tanabe KK.

FASEB J. 2000 Feb;14(2):301-11.

PMID:
10657986
11.

Oncolytic virus therapy using genetically engineered herpes simplex viruses.

Todo T.

Front Biosci. 2008 Jan 1;13:2060-4. Review.

PMID:
17981691
12.

Neurotropism of herpes simplex virus type 1 in brain organ cultures.

Braun E, Zimmerman T, Hur TB, Reinhartz E, Fellig Y, Panet A, Steiner I.

J Gen Virol. 2006 Oct;87(Pt 10):2827-37.

PMID:
16963740
13.

Restrictions that control herpes simplex virus type 1 infection in mouse brain ex vivo.

Cohen M, Braun E, Tsalenchuck Y, Panet A, Steiner I.

J Gen Virol. 2011 Oct;92(Pt 10):2383-93. doi: 10.1099/vir.0.031013-0. Epub 2011 Jun 22.

PMID:
21697348
14.

Combined oncolytic virotherapy with herpes simplex virus for oral squamous cell carcinoma.

Ogawa F, Takaoka H, Iwai S, Aota K, Yura Y.

Anticancer Res. 2008 Nov-Dec;28(6A):3637-45.

15.

Identification of virus resistant tumor cell subpopulations in three-dimensional uveal melanoma cultures.

Valyi-Nagy K, Dosa S, Kovacs SK, Bacsa S, Voros A, Shukla D, Folberg R, Valyi-Nagy T.

Cancer Gene Ther. 2010 Apr;17(4):223-34. doi: 10.1038/cgt.2009.73. Epub 2009 Nov 6.

PMID:
19893596
16.

Oncolytic herpes simplex virus type 1 and host immune responses.

Fukuhara H, Todo T.

Curr Cancer Drug Targets. 2007 Mar;7(2):149-55. Review.

PMID:
17346106
17.

Positron emission tomography of herpes simplex virus 1 oncolysis.

Kuruppu D, Brownell AL, Zhu A, Yu M, Wang X, Kulu Y, Fuchs BC, Kawasaki H, Tanabe KK.

Cancer Res. 2007 Apr 1;67(7):3295-300.

18.

"Armed" oncolytic herpes simplex viruses for brain tumor therapy.

Todo T.

Cell Adh Migr. 2008 Jul-Sep;2(3):208-13. Epub 2008 Jul 28.

19.

Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.

Watanabe D, Goshima F, Mori I, Tamada Y, Matsumoto Y, Nishiyama Y.

J Dermatol Sci. 2008 Jun;50(3):185-96. doi: 10.1016/j.jdermsci.2007.12.001. Epub 2008 Jan 15.

PMID:
18226503
20.

Calcium depletion enhances nectin-1 expression and herpes oncolytic therapy of squamous cell carcinoma.

Yu Z, Li S, Huang YY, Fong Y, Wong RJ.

Cancer Gene Ther. 2007 Aug;14(8):738-47. Epub 2007 May 25.

PMID:
17525764

Supplemental Content

Support Center